NYSE to Commence Delisting Proceedings Against Leju Holdings Limited (LEJU)
NYSE to Commence Delisting Proceedings Against Leju Holdings Limited (LEJU)
The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the American Depositary Shares (“ADSs”), each representing ten ordinary shares, par value $0.001 per share of Leju Holdings Limited (the “Company”) — ticker symbol LEJU — from the NYSE. Trading in the Company’s ADSs will be suspended immediately.
The Company is currently below compliance with Section 802.01B of the NYSE Listed Company Manual since the Company has a total market capitalization of less than $50 million over a 30 trading-day period and a stockholders’ equity of less than $50 million. NYSE Regulation reached its decision to delist the Company’s ADSs pursuant to Section 802.03 of the NYSE Listed Company Manual, because the Company submitted a business plan that did not demonstrate an ability to return to compliance with continued listing standards within 18 months of notice from the Exchange as required by Section 802.03 of the NYSE Listed Company Manual.
The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the ADSs upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.
Company Contact:
Investor Relations
Leju Holdings Limited
Phone: +86 (21) 60868396
E-mail: ir@leju.com
NYSE Contact:
NYSE Communications
PublicRelations-NYSE@ice.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240411546787/en/
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track